Vaxart Historical Cash Flow
| VXRT Stock | USD 0.74 0.00 0.000001% |
Analysis of Vaxart cash flow over time is an excellent tool to project Vaxart Inc future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Depreciation of 8.1 M or Other Non Cash Items of 90.6 K as it is a great indicator of Vaxart ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Vaxart Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Vaxart Inc is a good buy for the upcoming year.
Vaxart |
About Vaxart Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Vaxart balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Vaxart's non-liquid assets can be easily converted into cash.
Vaxart Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from Vaxart's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Vaxart Inc current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vaxart Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. At this time, Vaxart's Depreciation is comparatively stable compared to the past year. End Period Cash Flow is likely to gain to about 53.6 M in 2025, whereas Other Non Cash Items is likely to drop slightly above 90.6 K in 2025.
Vaxart cash flow statement Correlations
Click cells to compare fundamentals
Vaxart Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Vaxart cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 113.3M | 16.9M | (97.7M) | (11.3M) | (10.1M) | (9.6M) | |
| Free Cash Flow | (25.0M) | (65.0M) | (104.4M) | (72.3M) | (65.1M) | (61.8M) | |
| Depreciation | 2.7M | 4.2M | 5.8M | 8.6M | 7.8M | 8.1M | |
| Other Non Cash Items | (1.4M) | (3.4M) | (5.8M) | 106K | 95.4K | 90.6K | |
| Capital Expenditures | 1.2M | 5.2M | 9.6M | 1.9M | 1.7M | 1.6M | |
| Total Cash From Operating Activities | (23.8M) | (59.8M) | (94.8M) | (70.5M) | (63.4M) | (60.2M) | |
| Net Income | (32.2M) | (70.5M) | (107.8M) | (82.5M) | (74.2M) | (70.5M) | |
| End Period Cash Flow | 126.9M | 143.7M | 46.0M | 34.8M | 40.0M | 53.6M | |
| Change In Working Capital | 2.8M | (2.1M) | (4.7M) | (10.9M) | (12.5M) | (11.9M) | |
| Begin Period Cash Flow | 13.5M | 126.9M | 143.7M | 46.0M | 52.9M | 52.3M | |
| Other Cashflows From Financing Activities | 27.2M | 3.6M | 225K | 213K | 245.0K | 257.2K | |
| Total Cash From Financing Activities | 138.3M | 125.8M | 17.5M | 15.2M | 17.5M | 14.4M | |
| Sale Purchase Of Stock | 137.7M | 3.6M | 17.5M | (366K) | (420.9K) | (399.9K) | |
| Stock Based Compensation | 4.4M | 8.9M | 13.6M | 14.1M | 16.3M | 17.1M | |
| Change To Account Receivables | 3.3M | 263K | 51K | (3.0M) | (3.4M) | (3.3M) | |
| Investments | (1.2M) | (39.1M) | (10.8M) | 44.0M | 39.6M | 41.5M | |
| Change Receivables | (1.8M) | 3.3M | 263K | 51K | 58.7K | 55.7K | |
| Total Cashflows From Investing Activities | (850K) | (1.2M) | (49.1M) | (20.4M) | (18.4M) | (17.5M) | |
| Cash And Cash Equivalents Changes | 2.0M | 113.3M | 16.9M | (97.7M) | (88.0M) | (83.6M) | |
| Cash Flows Other Operating | 718K | (2.5M) | (5.2M) | (9.6M) | (11.0M) | (10.5M) | |
| Change To Operating Activities | 3.2M | (1.7M) | (4.0M) | (7.1M) | (6.4M) | (6.1M) | |
| Change To Netincome | 814K | 4.4M | 11.9M | 17.8M | 20.5M | 21.5M | |
| Change To Liabilities | 2.3M | 628K | (583K) | (5.0M) | (5.7M) | (6.0M) | |
| Issuance Of Capital Stock | 111.1M | 122.2M | 17.2M | 15.0M | 13.5M | 12.9M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Vaxart Stock Analysis
When running Vaxart's price analysis, check to measure Vaxart's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxart is operating at the current time. Most of Vaxart's value examination focuses on studying past and present price action to predict the probability of Vaxart's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxart's price. Additionally, you may evaluate how the addition of Vaxart to your portfolios can decrease your overall portfolio volatility.